In addition, an analysis of 358 RA patients treated with numerous bDMARDs, including TNF-α inhibitors, tocilizumab, and abatacept, found that change in NLR was related modestly to change in DAS28-ESR [16]. This evidence concerns the gene TNF and rheumatoid arthritis.